Abstract
Background
Angiogenesis plays a role in the pathogenesis of systemic lupus erythematosus (SLE). Both serum vascular endothelial growth factor (VEGF) and capillaroscopic abnormalities may reflect intensity of microcirculatory changes in the course of SLE.
Aims
To quantify serum VEGF level and its correlation with microvascular changes, assessed by nailfold capillaroscopy (NFC), and possible relationship with SLE activity.
Patients and methods
A total of 90 patients with SLE were subjected to detailed medical history and clinical examination and assessment of disease activity using the SLE Disease Activity Index score and organ damage using Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index. Laboratory investigations were done including autoantibodies [anti-nuclear antibody, anti-DNA, anti-cardiolipin (immunoglobulin G and immunoglobulin M), and lupus anticoagulant]. VEGF serum level was measured using enzyme-linked immunosorbent assay. NFC examination was done for recognition of NFC abnormalities.
Results
Serum VEGF level was elevated in the entire study group (mean of 831±572 ng/l), with a statistically highly significant correlation with Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index and SLE Disease Activity Index score of disease activity (r=0.349, P=0.001, and r=0.897, P<0.001, respectively), together with a significant positive correlation with the presence of nephritis (P=0.002), positive anti-double-stranded DNA (P≤0.001), and consumed C3 and C4 (P≤0.001), which are laboratory markers indicating lupus activity. Moreover, a higher serum VEGF level was associated with severe NFC changes with a statistically highly significant positive correlation with the capillary width (r=0.561, P<0.001), capillary length (r=0.411, P<0.001), and mean capillary density (r=0.308, P=0.003).
Conclusion
Increased serum VEGF level and progression of NFC score had been directly related to lupus activity and internal organ involvement, especially nephritis.
Article PDF
Similar content being viewed by others
References
Iman IE, Soha EI, Wael SE, Hanan MF, Amal HE. Assessment of vascular endothelial growth factor in systemic lupus erythematosus patients with anti-phospholipid syndrome. Egypt Rheumatol 2018; 41:1.
Ragab O, Ashmawy A, Abdo M, Mokbel A. Nailfold capilloroscopy in systemic lupus erythematosus. Egypt Rheumatol 2011; 33:61–67.
Petri M, Orbai AM, Alarcón GS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus‘. Arthritis Rheum 2012; 64:2677–2686.
Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29:288–291.
Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27:373–376.
Schips L, Dalpiaz O, Lipsky K, Langner C, Rehak P, Puerstner P, et al. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. Eur Urol 2007; 51:168–174.
Bărbulescu AL, Vreju AF, Bugă AM, Sandu RE, Criveanu C, Tudoraşcu DR, et al. Vascular endothelial growth factor in systemic lupus erythematosus–correlations with disease activity and nailfold capillaroscopy changes. Rom J Morphol Embryol 2015; 56:1011–1016.
Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, et al. Nailfold capillaroscopy in systemic lupus erythematosus. A systematic review and critical appraisal. Autoimm Rev 2018; 17:344–352.
Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S, Ciolkiewicz M. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities. Arch Immunol Ther Exp 2007; 55:179.
Moneib HA, Salem SA, Aly DG, Khedr HT, Wafaey HA, Hassan HE. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations. J Dermatol 2012; 39: 52–57.
Liu J, Wang X, Yang X, Ya Q, Wang S, Han W. Investigating the role of angiogenesis in systemic lupus erythematosus. Lupus 2015; 24:621–627.
Avihingsanon Y, Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, et al. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int 2006; 69:747–753.
Ghazali WSW, Iberahim R, Ashari NSM. Serum vascular endothelial growth factor (VEGF) as a biomarker for disease activity in lupus nephritis. Malay J Med Sci 2017; 24:62.
Zhou L, Lu G, Shen L, Wang L, Wang M. Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance. BioMed Res Int 2014; 2014:627126.
Navarro C, Candia-Zuniga L, Silveira LH, Rui V, Gaxiola M, Avila MC, et al. Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 2002; 11:21–24.
Heshmat NM, El-Kerdany TH. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Pediatr Allergy Immunol 2007; 18:346–353.
Ciolkiewicz M, Kuryliszyn-Moskal A, Klimiuk PA. Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients. Clin Rheumatol 2010; 29:175.
Ibrahim FF, Draz HM, Al Sherbeni HH. Serum VEGF and haemoglobin dielectric properties in patients with systemic lupus erythromatosus. J Med Sci 2008; 8:469–476.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hamza, S.M.H., Khalil, N.S., Hamoda, R.M. et al. Vascular endothelial growth factor in systemic lupus erythematosus in correlations with disease activity and nailfold capillaroscopic changes. Egypt J Intern Med 31, 943–950 (2019). https://doi.org/10.4103/ejim.ejim_28_19
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_28_19